News TagCloud
- Agreement
- Auris
- BioValley
- Board
- Drug
- EBIT
- European
- Genzyme
- Half
- Lonza
- Management
- Manufacturing
- Medical
- Novartis
- Novozymes
- Performance
- Phase
- QIAGEN
- Quarter
- RARE
- Results
- Roche
- Round
- Siegfried
- Straumann
- Syna
- Syngenta
- Third
- Unia
- announces
- commercial
- data
- disease
- growth
- holding
- million
- mondoBIOTECH
- named
- patients
- positive
- reporting
- reports
- research
- results
- revenues
- rights
- show
- significantly
- stable
- treatment
BioValley News
GE’s dual-energy GSI technology represents a new standard of visualization that helps address CT clinical imaging challenges
Cincinnati, OH - To address surgeons’ need for achieving strong vessel seals while remaining gentle on tissue in open surgery, Ethicon Endo-Surgery, Inc. (EES) announces the launch of its innovative ENSEAL G2 Super Jaw advanced...[more]
Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent
BRIDGEWATER, N.J. - Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced it will no longer pursue the development of the NEVO Sirolimus-Eluting Coronary...[more]
Cardinal Health, Prime Therapeutics Renew Primary Distribution Agreement
DUBLIN, Ohio and ST. PAUL, Minn. - Cardinal Health announced that it has signed a renewed, three-year agreement with Prime Therapeutics, one of the nation's leading pharmacy benefit managers, to continue to serve as its primary...[more]
Roche Children's Walk 2011: Employees worldwide walk on the same day to raise awareness for vulnerable children in Malawi and around the world
Every year since 2003 Roche employees raise awareness for children in need by walking to collect donations for day-care centres in Malawi and children’s charities in their own countries.[more]
Boehringer Ingelheim and Lilly's New Type 2 Diabetes Treatment Tradjenta Tablets for Adults Now Available in U.S. Pharmacies
RIDGEFIELD, Conn. and INDIANAPOLIS - Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) announced Tradjenta (linagliptin) tablets are now available by prescription in pharmacies across the United...[more]
Novartis application for expanded Menveo indication from 2 months of age accepted for review by FDA
Basel - Novartis announced that the US Food and Drug Administration (FDA) has accepted for review its supplemental Biologics License Application (sBLA) to expand the Menveo (Meningococcal [Groups A, C, Y and W-135]...[more]
Somdeb Bose Dasgupta wins an INSA medal for Young Scientists
Somdeb Bose Dasgupta, postdoctoral fellow in the laboratory of Prof. Jean Pieters at the Biozentrum, University of Basel, is among the recipients of the prestigious Indian National Science Academy Medal for Young Scientists in...[more]
Codman Neurovascular Launches ORBIT GALAXY Detachable Coil System
Raynham, MA - Codman & Shurtleff, Inc. (Codman), a global neuroscience and neurovascular company, announced the launch of the ORBIT GALAXY Detachable Coil System (ORBIT GALAXY), the first complete family of complex, random loop...[more]
Abbott Receives FDA Approval For CREON (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreatic Insufficiency Due To Cystic Fibrosis
Abbott Park, Illinois (NYSE: ABT) - Abbott announced that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatic...[more]
Former Chairman and CEO of Aetna Inc., Ronald Williams, Appointed to Johnson & Johnson Board of Directors
NEW BRUNSWICK, N.J. - Ronald A. Williams, former chairman and chief executive officer (CEO) of Aetna Inc., has been appointed to the Board of Directors of Johnson & Johnson (NYSE: JNJ), the world's most comprehensive and broadly...[more]


